These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 37496076)

  • 21. Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model.
    Chen W; Huang Q; Lazdon EK; Gomes A; Wong M; Stephens E; Royal TG; Frenkel D; Cai W; Kahn CR
    Proc Natl Acad Sci U S A; 2023 May; 120(21):e2220684120. PubMed ID: 37186836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p47
    Gong P; Chen YQ; Lin AH; Zhang HB; Zhang Y; Ye RD; Yu Y
    Alzheimers Res Ther; 2020 Nov; 12(1):146. PubMed ID: 33183342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains.
    Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS
    Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APP/PS1 mice overexpressing SREBP-2 exhibit combined Aβ accumulation and tau pathology underlying Alzheimer's disease.
    Barbero-Camps E; Fernández A; Martínez L; Fernández-Checa JC; Colell A
    Hum Mol Genet; 2013 Sep; 22(17):3460-76. PubMed ID: 23648430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
    Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
    J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
    Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
    Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: implications for Alzheimer disease pathogenesis.
    Terron HM; Parikh SJ; Abdul-Hay SO; Sahara T; Kang D; Dickson DW; Saftig P; LaFerla FM; Lane S; Leissring MA
    Alzheimers Res Ther; 2024 Apr; 16(1):70. PubMed ID: 38575959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
    Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
    Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thioflavin-positive tau aggregates complicating quantification of amyloid plaques in the brain of 5XFAD transgenic mouse model.
    Shin J; Park S; Lee H; Kim Y
    Sci Rep; 2021 Jan; 11(1):1617. PubMed ID: 33452414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer's Disease.
    Delgado-Peraza F; Nogueras-Ortiz CJ; Volpert O; Liu D; Goetzl EJ; Mattson MP; Greig NH; Eitan E; Kapogiannis D
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.
    Ciavardelli D; Silvestri E; Del Viscovo A; Bomba M; De Gregorio D; Moreno M; Di Ilio C; Goglia F; Canzoniero LM; Sensi SL
    Cell Death Dis; 2010 Oct; 1(10):e90. PubMed ID: 21368863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
    DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
    Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A small-molecule microtubule-stabilizing agent safely reduces Aβ plaque and tau pathology in transgenic mouse models of Alzheimer's disease.
    Yao Y; Muench M; Alle T; Zhang B; Lucero B; Perez-Tremble R; McGrosso D; Newman M; Gonzalez DJ; Lee VM; Ballatore C; Brunden KR
    Alzheimers Dement; 2024 Jul; 20(7):4540-4558. PubMed ID: 38884283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.
    Sakae N; Liu CC; Shinohara M; Frisch-Daiello J; Ma L; Yamazaki Y; Tachibana M; Younkin L; Kurti A; Carrasquillo MM; Zou F; Sevlever D; Bisceglio G; Gan M; Fol R; Knight P; Wang M; Han X; Fryer JD; Fitzgerald ML; Ohyagi Y; Younkin SG; Bu G; Kanekiyo T
    J Neurosci; 2016 Mar; 36(13):3848-59. PubMed ID: 27030769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Aβ Clearance.
    Zhang H; Chen W; Tan Z; Zhang L; Dong Z; Cui W; Zhao K; Wang H; Jing H; Cao R; Kim C; Safar JG; Xiong WC; Mei L
    J Neurosci; 2020 Jul; 40(28):5347-5361. PubMed ID: 32457076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senescence-related impairment of autophagy induces toxic intraneuronal amyloid-β accumulation in a mouse model of amyloid pathology.
    Suelves N; Saleki S; Ibrahim T; Palomares D; Moonen S; Koper MJ; Vrancx C; Vadukul DM; Papadopoulos N; Viceconte N; Claude E; Vandenberghe R; von Arnim CAF; Constantinescu SN; Thal DR; Decottignies A; Kienlen-Campard P
    Acta Neuropathol Commun; 2023 May; 11(1):82. PubMed ID: 37198698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.